The Download: keeping up with AI, and the future of IVF
Why this matters: a development in AI with implications for how people work, create, and decide.
This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. Stay on top of what’s going on in AI this summer Here at MIT Technology Review, we understand exactly how relentless the pace of news from the world of artificial intelligence feels. New models and capabilities crop up as fast as we can cover them, and the ripple effects they send through tech and wider society are never far behind. Our unique strength lies in cutting through the day-to-day noise to help you understand what’s really happening, and what lies around the corner. That’s why we created our list of 10 Things That Matter in AI Right Now, unveiled at our flagship AI event EmTech AI a few weeks back (check the list out if you haven’t already!) And it’s why we publish so many stories dedicated to explaining how AI works, and what’s coming next. We also regularly run live subscriber-only Roundtables events—you can still catch up on last week’s session, where we explored how AI might enter the physical realm via world models. Right now, there’s a 25% discount on subscriptions. Sign up now to deepen your understanding of AI this summer. You can also join the conversation by subscribing to The Algorithm, our free weekly newsletter all about the latest in AI. MIT Technology Review Narrated: what’s next for IVF IVF has brought millions of babies into the world over the last four decades. But the process can still be slow, painful, and expensive—and far from guaranteed to work. Now, a wave of new technologies aims to change that. Researchers are using AI to identify promising sperm and embryos, developing robotic systems that could automate parts of the IVF process, and even exploring controversial genetic editing techniques designed to prevent inherited disease. The technologies could make IVF more effective and accessible. But they’re also raising difficult ethical questions about how far reproductive medicine